Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Other non-cash items (2024 - 2025)

Updated

Analysis

Impact Biomedical (IBO) Other non-cash items (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,148.60 Bn 1,117.19 Bn 19.71 Bn
2 Johnson & Johnson 637.24 Bn 557.10 Bn 17.30 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn
4 Merck 356.72 Bn 311.10 Bn 12.21 Bn
5 Novartis Ag 301.65 Bn 265.64 Bn 11.24 Bn
6 Astrazeneca 265.03 Bn 238.72 Bn 12.86 Bn
7 Amgen 239.14 Bn 194.54 Bn 7.24 Bn
8 Gilead Sciences 194.82 Bn 169.02 Bn 6.22 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn
10 Impact Biomedical 409.72 Mn 412.92 Mn 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.82 Mn
Sep 30, 2025 268,000.00
Jun 30, 2025 12.94 Mn
Mar 31, 2025 271,000.00
Dec 31, 2024 872,000.00
Sep 30, 2024 -5.67 Mn
API Access

Impact Biomedical Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=IBO&period=max&api_key=YOUR_API_KEY